Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.6 | 1.41 |
NAV | ₹105.75 | ₹167.90 |
Fund Started | 11 Nov 2013 | 26 Aug 2010 |
Fund Size | ₹25062.36 Cr | ₹63006.73 Cr |
Exit Load | Exit load of 1% for investments beyond 10% if redeemed within 12 months | Exit load of 1% if redeemed within 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 8.15% | 0.81% |
3 Year | 23.97% | 29.69% |
5 Year | 31.16% | 38.67% |
1 Year
3 Year
5 Year
Equity | 89.29% | 95.71% |
Cash | -1.52% | 4.29% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Krishna Institute of Medical Sciences Ltd | 2.94% |
Brigade Enterprises Ltd. | 2.69% |
Cholamandalam Financial Holdings Ltd. | 2.67% |
CCL Products (India) Ltd. | 2.45% |
Kaynes Technology India Ltd. | 2.18% |
Blue Star Ltd. | 2.17% |
Nifty 50 | 1.94% |
Narayana Hrudayalaya Ltd. | 1.76% |
Multi Commodity Exchange Of India Ltd. | 1.72% |
PB Fintech Ltd. | 1.68% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 2.05% |
Multi Commodity Exchange Of India Ltd. | 1.94% |
Kirloskar Brothers Ltd. | 1.29% |
Tube Investments Of India Ltd. | 1.21% |
State Bank of India | 1.17% |
Apar Industries Ltd. | 1.16% |
Bharat Heavy Electricals Ltd. | 1.13% |
Karur Vysya Bank Ltd. | 1.12% |
Pfizer Ltd. | 1.07% |
Paradeep Phosphates Ltd. | 1.07% |
Name | Mayank Hyanki | Akshay Sharma |
Start Date | 05 Apr 2024 | 01 Dec 2022 |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation from a diversified portfolio of predominantly equity & equity related instruments of small cap companies. | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related instruments of small cap companies. |
Launch Date | 11 Nov 2013 | 26 Aug 2010 |
Description
Launch Date